Status:
COMPLETED
International COVID19 Clinical Evaluation Registry,
Lead Sponsor:
IVAN J NUÑEZ GIL
Conditions:
COVID 19
Eligibility:
All Genders
Brief Summary
The investigators propose to select all COVID 19 patients attended in any health center (with in hospital beds), who have been discharged or have died at the time of the evaluation. The main objectiv...
Detailed Description
INTRODUCTION. The disease caused by the new respiratory virus (coronavirus) designated as SARS-CoV-2 has recently been classified as a pandemic by the WHO. With an increasing number of confirmed case...
Eligibility Criteria
Inclusion
- Patients discharged (deceased or alive) from any hospital center with a confirmed diagnosis or a COVID-19 high suspicion.
Exclusion
- There are no exclusion criteria, except for the patient's explicit refusal to participate.
Key Trial Info
Start Date :
March 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
8168 Patients enrolled
Trial Details
Trial ID
NCT04334291
Start Date
March 23 2020
End Date
May 31 2020
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Lclinico San Carlos
Madrid, Spain, 28040